GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » EBITDA Margin %

Median Diagnostics (XKRX:233250) EBITDA Margin % : 11.53% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Median Diagnostics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Median Diagnostics's EBITDA for the six months ended in Dec. 2024 was ₩1,406 Mil. Median Diagnostics's Revenue for the six months ended in Dec. 2024 was ₩12,194 Mil. Therefore, Median Diagnostics's EBITDA margin for the quarter that ended in Dec. 2024 was 11.53%.


Median Diagnostics EBITDA Margin % Historical Data

The historical data trend for Median Diagnostics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Diagnostics EBITDA Margin % Chart

Median Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.74 23.62 3.43 -6.21 11.53

Median Diagnostics Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.74 23.62 3.43 -6.21 11.53

Competitive Comparison of Median Diagnostics's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Median Diagnostics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Diagnostics's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Median Diagnostics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Median Diagnostics's EBITDA Margin % falls into.


;
;

Median Diagnostics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Median Diagnostics's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=1406.281/12194.441
=11.53 %

Median Diagnostics's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=1406.281/12194.441
=11.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Median Diagnostics  (XKRX:233250) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Median Diagnostics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Median Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
878 Seoul Office, Dongnae-dong, Kangwon-do, Chuncheon, KOR, 200-883
Median Diagnostics Inc is a Korea based company engaged in providing IVD solutions and veterinary diagnostics services. Its solutions portfolio covers avian influenza diagnosis solution, foot and mouth disease diagnosis solution, African Pig fever solution and others. The company offers ELISA diagnostic products, rapid test kit, molecular diagnosis products, standard diagnosis products and biologicals.

Median Diagnostics Headlines

No Headlines